LONDON, ON — In a retrospective study of >600,000 seniors, those who received a new prescription of a macrolide antibiotic (azithromycin, clarithromycin, or erythromycin) did not have a greater ...

NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis ...

Please provide your email address to receive an email when new articles are posted on . Children born to mothers who used opioids and macrolide antibiotics do not have increased risks for major birth ...

Taking a certain class of antibiotics while pregnant has been linked to severe infant birth defects, according to a study published in The BMJ. U.K. researchers studied 104,605 children born from 1990 ...

According to a meta-analysis, long-term macrolide therapy at low doses could reduce acute exacerbations in patients with chronic obstructive pulmonary disease. Long-term macrolide therapy at low doses ...

Analysis of the cases found that standard doses of both oral and intravenous macrolide administration were associated with SNHL. Results of a systematic review including 44 publications found that, ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning on the use of hydroxychloroquine (HCQ) concurrently with a macrolide antibiotic such as azithromycin. The alert ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a next-generation antibiotics company developing macrolides that are first-in-class with Gram-negative activity for a broad range of multi ...

A new study published in the journal BMJ in February 2020 reports that macrolide or penicillin antibiotic consumption in pregnancy could be linked to several adverse health outcomes in children. These ...

Pregnant women who take certain types of antibiotics have a greater risk of having a child with birth defects, a study has found. Using data on over 100,000 children, researchers found that women ...

The emergence of antibiotic resistance during treatment for pneumococcal infection is exceedingly rare. 1 To our knowledge, there is no previous report of a genetically characterized, ...

NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis ...